122 related articles for article (PubMed ID: 11964015)
1. Genetic aspects of pituitary tumors.
Spada A
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1213-6; discussion 1261-2. PubMed ID: 11964015
[TBL] [Abstract][Full Text] [Related]
2. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors.
Shi Y; Tang D; Deng J; Su C
Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233
[TBL] [Abstract][Full Text] [Related]
3. G-proteins and hormonal signalling in human pituitary tumors: genetic mutations and functional alterations.
Spada A; Vallar L; Faglia G
Front Neuroendocrinol; 1993 Jul; 14(3):214-32. PubMed ID: 8102338
[TBL] [Abstract][Full Text] [Related]
4. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
[TBL] [Abstract][Full Text] [Related]
5. Hormonal signaling and pituitary adenomas.
Spada A; Lania A; Mantovani G
Neuroendocrinology; 2007; 85(2):101-9. PubMed ID: 17337884
[TBL] [Abstract][Full Text] [Related]
6. G protein abnormalities in pituitary adenomas.
Spada A; Lania A; Ballarè E
Mol Cell Endocrinol; 1998 Jul; 142(1-2):1-14. PubMed ID: 9783897
[TBL] [Abstract][Full Text] [Related]
7. Absence of activating mutations of CXCR4 in pituitary tumours.
Lee YH; Noh TW; Lee MK; Jameson JL; Lee EJ
Clin Endocrinol (Oxf); 2010 Feb; 72(2):209-13. PubMed ID: 19473177
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the molecular biology of growth-hormone secreting human pituitary tumours.
Adams EF; Buchfelder M; Hüttner A; Moreth S; Fahlbusch R
Exp Clin Endocrinol; 1993; 101(1):12-6. PubMed ID: 8477819
[TBL] [Abstract][Full Text] [Related]
9. GTPase-inhibiting mutations activate the alpha-chain of Gs in human tumours.
Vallar L
Biochem Soc Symp; 1990; 56():165-70. PubMed ID: 2124121
[TBL] [Abstract][Full Text] [Related]
10. [Genetic changes in human pituitary adenomas].
Spada A; Lania A
Minerva Endocrinol; 2003 Mar; 28(1):27-37. PubMed ID: 12621361
[TBL] [Abstract][Full Text] [Related]
11. Oncogenesis and mutagenesis of pituitary tumors.
Sonabend AM; Musleh W; Lesniak MS
Expert Rev Anticancer Ther; 2006 Sep; 6 Suppl 9():S3-14. PubMed ID: 17004855
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic mechanisms of tumorigenesis.
Farrell WE
Horm Metab Res; 2005 Jun; 37(6):361-8. PubMed ID: 16001328
[TBL] [Abstract][Full Text] [Related]
13. Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis.
van Staveren WC; Solís DW; Delys L; Venet D; Cappello M; Andry G; Dumont JE; Libert F; Detours V; Maenhaut C
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):413-8. PubMed ID: 16381821
[TBL] [Abstract][Full Text] [Related]
14. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.
Iwata T; Yamada S; Mizusawa N; Golam HM; Sano T; Yoshimoto K
Clin Endocrinol (Oxf); 2007 Apr; 66(4):499-502. PubMed ID: 17371465
[TBL] [Abstract][Full Text] [Related]
15. Genetics of pituitary tumors: Focus on G-protein mutations.
Lania A; Mantovani G; Spada A
Exp Biol Med (Maywood); 2003 Oct; 228(9):1004-17. PubMed ID: 14530508
[TBL] [Abstract][Full Text] [Related]
16. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
17. The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas.
De Martino I; Visone R; Palmieri D; Cappabianca P; Chieffi P; Forzati F; Barbieri A; Kruhoffer M; Lombardi G; Fusco A; Fedele M
Endocr Relat Cancer; 2007 Sep; 14(3):875-86. PubMed ID: 17914116
[TBL] [Abstract][Full Text] [Related]
18. Activating mutations of the Gs alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors.
Ballaré E; Mantovani S; Lania A; Di Blasio AM; Vallar L; Spada A
J Clin Endocrinol Metab; 1998 Dec; 83(12):4386-90. PubMed ID: 9851782
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic studies of sporadic pituitary tumors.
Boggild MD; Jenkinson S; Pistorello M; Boscaro M; Scanarini M; McTernan P; Perrett CW; Thakker RV; Clayton RN
J Clin Endocrinol Metab; 1994 Feb; 78(2):387-92. PubMed ID: 8106627
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy?
Beuschlein F; Hancke K; Petrick M; Göbel H; Honegger J; Reincke M
Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):214-8. PubMed ID: 15891957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]